10-Q: Brown & Brown Q3: Accession Fuels Revenue, EPS Dips

Brown & Brown reports significant revenue growth driven by the Accession acquisition, though net income and diluted EPS saw a slight decline amidst increased expenses and debt.

Summary

• Total revenues for the three months ended September 30, 2025, increased by 35.4% to $1,606 million, up from $1,186 million in the prior year.
• Net income attributable to the Company for Q3 2025 decreased by 3.0% to $227 million, compared to $234 million in Q3 2024.
• Diluted earnings per share (EPS) for Q3 2025 was $0.68, a decrease from $0.81 in Q3 2024.
• The company completed 37 acquisitions during the nine months ended September 30, 2025, including the significant acquisition of RSC Topco, Inc. (Accession) on August 1, 2025, for $9,598 million.
• The Accession acquisition was funded by $8,293 million in cash and $612 million in common stock, with $750 million in escrowed consideration.
• Organic Revenue growth rate for Q3 2025 was 3.5%, a slowdown from 9.5% in Q3 2024.
• Total debt increased by $3,904 million to $7,728 million as of September 30, 2025, primarily due to financing the Accession acquisition.
• The company reorganized its business into two reportable segments: Retail and Specialty Distribution, effective Q3 2025, following the Accession acquisition.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the Accession acquisition significantly boosts revenue and market presence, the immediate impact on net income and EPS is negative due to substantial acquisition-related expenses, increased debt, and higher amortization. The slowdown in organic growth is also a concern. However, the strategic nature of the acquisition, increased dividend, and expanded share repurchase authorization provide a positive long-term outlook.

Positives

• Total revenues increased significantly by 35.4% for Q3 2025 and 18.6% for the nine months ended September 30, 2025, largely driven by strategic acquisitions.
• Profit-sharing contingent commissions saw substantial growth, increasing by 170.4% to $73 million in Q3 2025 and 46.4% to $161 million for the nine months ended September 30, 2025, due to improved underwriting results and increased premium volume.
• Investment and other income grew by 80.6% in Q3 2025 and 45.5% for the nine months ended September 30, 2025, boosted by interest income from proceeds held for the Accession acquisition.
• The company successfully completed a major acquisition (Accession) and 36 other smaller acquisitions, expanding its market presence and capabilities.
• The Board of Directors approved an increase in the quarterly cash dividend to $0.165 per share, payable November 12, 2025, signaling confidence.
• An additional $1,251 million increase to the share repurchase authorization was approved, bringing total remaining capacity to $1,500 million, indicating a commitment to shareholder returns.

Negatives

• Net income attributable to the Company decreased by 3.0% in Q3 2025 and only increased by 0.9% for the nine months ended September 30, 2025, despite significant revenue growth.
• Diluted EPS declined by 16.0% to $0.68 in Q3 2025 and by 5.86% to $2.57 for the nine months ended September 30, 2025.
• Organic Revenue growth rate slowed to 3.5% in Q3 2025 from 9.5% in Q3 2024, and to 4.6% for the nine months ended September 30, 2025, from 9.4% in the prior year, indicating slower underlying growth.
• Total expenses increased disproportionately by 49.0% in Q3 2025, driven by higher employee compensation and benefits, other operating expenses (including acquisition/integration costs), amortization, and interest expense.
• Interest expense doubled in Q3 2025 to $100 million and increased by 34.0% for the nine months ended September 30, 2025, due to higher debt balances from acquisition financing.
• Amortization expense more than doubled in Q3 2025 to $93 million and increased by 49.6% for the nine months ended September 30, 2025, reflecting new intangibles from recent acquisitions.
• The change in estimated acquisition earn-out payables resulted in a charge of $11 million in Q3 2025, compared to a credit of $8 million in Q3 2024.

Risks

• The anticipated benefits and synergies from the Accession acquisition may not be fully realized or may take longer than expected, potentially disrupting existing operations.
• The significant increase in indebtedness due to the Transaction financing could reduce business flexibility and increase interest expense.
• Assumptions made regarding the Transaction, including future revenue, expenses, and integration costs, may prove to be materially inaccurate.
• Risks related to Accession's business, including underwriting risk in certain captive insurance companies, could lead to claims expenses not covered by reinsurance.
• Uncertainty regarding the outcome of litigation against Accession's subsidiary, Oxford Risk Management Group LLC, concerning financial guarantee and final judgment preservation policies for segregated captive cells.
• Potential IRS investigations into 831(b) elections for captive insurance companies, which could harm the business if non-compliance is found or guidance changes.
• Inability to hire, retain, and develop qualified employees, or the loss of key personnel, could negatively impact operations.
• Cybersecurity attacks or other IT/data security interruptions could impact operations or third-party support.
• Acquisition-related risks, such as difficulty identifying suitable candidates, completing acquisitions, or successfully integrating acquired businesses.
• Risks associated with international operations, which may require more management time and expense to achieve profitability.
• The need for additional resources and time to respond to rapid technological change, including artificial intelligence and robotic processing automation.
• Loss of or significant changes to insurance company or intermediary relationships could result in loss of capacity, increased expense, or decreased commissions.
• The effect of natural disasters on profit-sharing contingent commissions, insurer capacity, or claims expenses within capitalized captive insurance facilities.
• Adverse economic conditions, political conditions (including government shutdowns), outbreaks of war, disasters, or regulatory changes in key business regions.
• Fluctuations in commission revenue due to factors outside of the company's control, such as premium rate levels or insurable exposure units.
• The effects of significant or sustained inflation or higher interest rates on financial performance.
• Limitations of the system of disclosure and internal controls and procedures in preventing errors or fraud.
• Increasing scrutiny and changing laws and expectations from regulators, investors, and customers regarding environmental, social, and governance (ESG) practices.
• The possibility that goodwill may become impaired in the future due to intangible asset risk.

Future Outlook

The company anticipates continued growth through strategic acquisitions and organic initiatives, while managing increased debt and integration costs from the Accession acquisition. It expects to maintain sufficient liquidity through existing cash, investments, and credit facilities. The company is evaluating new accounting pronouncements and the impact of the One Big Beautiful Bill Act (OBBBA) on its financial results.

Management Comments

• Income before income taxes for the three months ended September 30, 2025, decreased from the third quarter of 2024 by $6 million or 1.9%, due to Acquisition/Integration Costs associated with the acquisition of Accession and increases in the change in estimated acquisition earnout payables, partially offset by Organic Revenue growth, leveraging our expense base, net new business and income from acquisitions completed in the past twelve months.
• We believe that its existing cash, cash equivalents, short-term investment portfolio and funds generated from operations, together with the funds available under the Revolving Credit Facility and the Loan Agreement, will be sufficient to satisfy its normal liquidity needs, including principal payments on our long-term debt, for the next twelve months and in the long term.

Industry Context

The company operates in a dynamic insurance intermediary market, characterized by ongoing consolidation through acquisitions. While the company's Retail segment experienced moderated growth due to slowing rate increases and some rate decreases, the Specialty Distribution segment saw strong profit-sharing contingent commissions. The acquisition of Accession significantly enhances its North American distribution platform, particularly in specialty insurance and risk management, positioning it for broader market reach. The industry faces challenges from rapid technological change, including AI, and increasing regulatory scrutiny on areas like ESG and captive insurance structures (e.g., IRS focus on 831(b) elections).

Comparison to Industry Standards

• The filing does not provide specific comparisons to named comparable companies, projects, or global benchmarks. However, the company's strategy of growth through acquisitions and focus on specialized insurance segments (like captive solutions and wholesale brokerage) aligns with broader trends in the insurance intermediary sector where scale and niche expertise are increasingly valued.

Corporate Governance

Legal Proceedings

• The company is involved in numerous pending or threatened proceedings arising in the ordinary course of business, with potential for substantial damages, including punitive or extraordinary damages.
• Litigation is pending against Accession's subsidiary, Oxford Risk Management Group LLC, regarding the 2024 restructuring of financial guarantee and final judgment preservation policies for segregated captive cells (FG Policies). The ultimate outcome, including remedies or damage awards, is uncertain.
• The company's results of operations could be negatively impacted if claims related to the FG Policies exceed the value of the cash and stock held in the indemnity escrow fund from the Accession merger.
• Potential IRS investigations into 831(b) elections for captive insurance companies, similar to those faced by peers, could harm the business if non-compliance is found or guidance changes.

Stakeholder Impact

• Shareholders: Experienced dilution from the common stock offering, a temporary dip in EPS, but benefit from increased dividends and a larger share repurchase authorization, signaling long-term value creation from the Accession acquisition.
• Employees: Integration of Accession's workforce and potential for new hires, but also potential for integration challenges and changes in compensation programs.
• Customers: Benefit from an expanded range of insurance products and services, particularly in specialty and risk management areas, due to the Accession acquisition.
• Creditors: Face increased exposure due to the significant rise in the company's total debt, though the company states it is in compliance with all debt covenants.
• Regulatory Authorities: Increased scrutiny, particularly regarding Accession's captive insurance operations and 831(b) elections, and ongoing compliance with various laws and regulations.

Next Steps

• Payment of a quarterly cash dividend of $0.165 per share on November 12, 2025.
• Scheduled principal payments on term loans in December 2025.
• Continued assessment of the One Big Beautiful Bill Act (OBBBA) provisions and their impact on financial position, results of operations, and cash flows.
• Evaluation of new FASB disclosure requirements (ASU 2024-03 and ASU 2023-09) for future implementation.
• Resolution of claims related to certain indemnification matters described in the Merger Agreement for the Accession acquisition, which will determine the release of escrowed funds.

Key Dates

Recommendation

The filing presents a mixed picture. The Accession acquisition is a transformative event, significantly boosting revenue and expanding market reach, which is a long-term positive. However, the immediate financial impact includes a decline in net income and EPS, a slowdown in organic growth, and a substantial increase in debt and expenses. While the increased dividend and share repurchase authorization are positive signals, the integration risks and the temporary drag on profitability warrant a 'hold' recommendation. Investors should monitor the successful integration of Accession, the realization of anticipated synergies, and the trajectory of organic growth and profitability in subsequent quarters before considering a 'buy' or 'sell'.

Keywords

Insurance Brokerage, SEC Filing, 10-Q, Brown & Brown, BRO, Accession Acquisition, Financial Results, Q3 2025, Organic Revenue Growth, Profit-Sharing Commissions, Debt Financing, Insurance Programs, Specialty Distribution, Risk Management, Captive Insurance, Share Repurchase, Dividends